Lorlatinib, Sotorasib, Adagrasib

Lorlatinib is actually against ROS1, but Sotorasib and Adagrasib are designed to target KRAS G12C

Map: A patient with Urothelial cancer (1038)
Node: 19710
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway